Crafting Cells for Cures
AI‑Engineered Human Mini‑Hearts. Predictive Drug Discovery. Platform‑Scale Biology.
CytoHub combines high‑fidelity human cardiac biology with AI‑driven
multimodal analytics to deliver reproducible, human‑relevant insight
that accelerates safer drug development and supports diverse
cardiac therapeutic programs. Our Platform unites standardized
biological products, contract research, and AI-driven data
orchestration to reduce uncertainty and expedite decisions.
multimodal analytics to deliver reproducible, human‑relevant insight
that accelerates safer drug development and supports diverse
cardiac therapeutic programs. Our Platform unites standardized
biological products, contract research, and AI-driven data
orchestration to reduce uncertainty and expedite decisions.
Cardiac Drug Development Is Broken
Up to 90% of drug candidates fail in clinical development. Animal models and simplified cell systems routinely
fail to replicate human cardiac biology, driving late‑stage attrition, higher costs, and delayed programs.
fail to replicate human cardiac biology, driving late‑stage attrition, higher costs, and delayed programs.
Limited Translatability
Existing models lack tissue architecture, multicellular interactions, and coordinated electrophysiology.
High Cost & Long Timelines
Late failures inflate development budgets
and extend time to market.
Transforming How Cardiac Science Is Done
CytoHub delivers an integrated platform that pairs three‑dimensional human cardiac assembloids with a modular AI analytics
engine to produce reproducible structural, physiological, functional, and molecular readouts early in development.
CardioVive™ — The Predictive Human Mini‑Heart
A standardized iPSC‑derived mini‑heart engineered to recapitulate ~96% of native cardiac cell‑type diversity, including cardiomyocytes, fibroblasts, endothelial cells, macrophages, and neural crest‑derived populations. CardioVive exhibits reproducible beating, electrophysiology,
and tissue‑level behavior suitable for safety, efficacy, and disease modeling across therapeutic programs.
BioEngineAI™ — The Operating System for Biological Data
An AI-driven multimodal analytics and data‑orchestration engine that ingests, quality‑controls, and interprets complex datasets. BioEngineAI enables consistent feature extraction, comparative analysis across donors and conditions, and traceable, reproducible outputs that scale with data volume.
Why Now?
Regulatory Momentum
Agencies are advancing New Approach Methodologies and reducing reliance on animal testing.
Scientific and Commercial Tailwinds
Growth in cell and gene therapy and in vitro modeling markets increases demand for human‑relevant platforms.
Operational Readiness
Standardized manufacturing and embedded analytics enable reproducible, scalable workflows that support discovery and preclinical programs.
Why CytoHub Stands Apart
3D biological complexity that reproduces tissue architecture
and multicellular interactions.
Fidelity with reproducibility via standardized manufacturing
and integrated QC.
Integrated multimodal
analytics that deliver
traceable, comparable results.
Roadmap to predictive modeling through HeartSync™ for in‑silico forecasting as validation scales.
Our Team
Leadership Team
Scientific Advisory Board
World‑class experts in stem‑cell biology, cardiac engineering, and translational medicine.
CytoHub is advised by a panel of industry and technical experts who provide guidance across
cardiac biology, manufacturing and operations, and strategic commercialization.
Resources & Press
Human heart assembloids with autologous tissue-resident macrophages recreate physiological immuno-cardiac interactions
Read moreSelf-assembling human heart organoids for the modeling of cardiac development and congenital heart disease
Read moreER stress and lipid imbalance drive diabetic embryonic cardiomyopathy in an organoid model of human heart development
Read moreSelf-organizing human heart assembloids with autologous and developmentally relevant cardiac neural crest-derived tissues
Read moreA patterned human primitive heart organoid model generated by pluripotent stem cell self-organization
Read moreContact Us
For scientific collaborations, commercial partnerships, or investment inquiries, email info@cytohub.com or submit a message through our contact form.
"*" indicates required fields